| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +11,000 | 100% | $1.81 | +$19,912 |
| Sells | 0 | ||||
| Net | +1 | +11,000 | 100% | +$19,912 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 10%+ Owner | $5,534,275 | 14 Nov 2024 | ||
| GERALD M. LIEBERMAN | Director | $823,723 | 01 Jan 2026 | ||
| Miranda Jayne Toledano | Chief Executive Officer, Director | $772,186 | +$19,912 | +2.6% | 29 Dec 2025 |
| Phillip Schwartz | President of R&D, Director | $601,336 | 20 Jan 2022 | ||
| Sean Ellis | Director | $382,634 | 01 Jan 2026 | ||
| Dana Yaacov-Garbeli | Chief Financial Officer | $232,876 | 16 Jul 2025 | ||
| Haya Taitel | Director | $217,439 | 01 Jan 2026 | ||
| Gregory Burshtein | Chief of R&D | $208,970 | 16 Jul 2025 | ||
| Yonatan Malca | Director | $185,024 | 01 Jan 2026 | ||
| GERALD M. OSTROV | Director | $180,820 | 01 Jan 2026 | ||
| Hillel Galitzer | Chief Operating Officer | $153,974 | 28 Apr 2025 | ||
| Ramesh Ratan | U.S.based CFO | $9,900 | 19 Jan 2022 | ||
| SPIROS JAMAS | Chief Executive Officer | $9,900 | 18 Jan 2022 | ||
| Ron Mayron | Director | 01 Jan 2024 | |||
| Arthur C. Santora II | Chief Medical Officer | 24 Apr 2023 | |||
| ROGER GARCEAU | Director | 01 Jan 2024 | |||
| Leslie Velka Gautam | Chief Business Officer | 08 May 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|